Abstract
Background/Aims: Apoptosis plays an important role in shaping the repertoire of lymphocytes and in regulating the size of the mature lymphocyte pool. The best-defined regulators of apoptosis in T cells are members of the Fas and Bcl families. Fas/FasL pathway is critically involved in the elimination of mature, self-reactive lymphocytes. Bcl-2 protein is important for lymphocyte survival in response to growth factors and various activating stimuli. We have compared the role of CD4+, CD8+, Fas, FasL and Bcl-2 in spontaneous apoptosis of T lymphocytes from cord blood and tested there is or not relation to gender.
Patients and Methods: We have introduced 28 late preterm newborns to our studies, 15 females and 13 males. Blood was collected from umbilical artery immediately after cutting cord. We have determined the following parameters: the per cent of CD4+ and CD8+ lymphocytes, the Fas and FasL phenotype and Bcl-2 using flow cytometer Coulter PC 500, Krefeld, Germany.
Results: We have found the increase per cent of CD4+ in females 56.10 %, in relation to males 38.15 %. The same per cent was found for CD8+ in both gender: 19.60 % females, 17.35 % males.
The antigen Fas (CD95) was more expressed in females: on CD4+ 12.80 %, CD8+ 8.15 %, in comparison to males: CD4+ 9.89 %, CD8+ 6.06 %. FasL (CD95L) was lower per cent in females: both on CD4+ 6.92 %, CD8+ 5.68 %, in relation to males: CD4+ 8.94 %, CD8+ 7.04 %. Bcl-2 was a little lower in females on CD4+ 96.9 % and evidently lower on CD8+ 79.14%. In males we noted on CD4+ 97.40% and on CD8+ 93.01 %. Summarizing our findings we can underline T lymphocytes in females are more activated, what indicate Fas. Inhibitor of apoptosis Bcl-2 is less expressed in females, in comparison to males lymphocytes.
Conclusion: Our preliminary results seems to indicate spontaneous apoptosis of T lymphocytes is more expressed in female newborns.
N . | Gender . | Lymphocyte T . | % . | Fas % . | FasL % . | Bcl-2 % . |
---|---|---|---|---|---|---|
15 | Female | CD4+ | 56.10 | 12.80 | 6.92 | 96.90 |
13 | Male | 38.15 | 9.89 | 8.94 | 97.40 | |
15 | Female | CD8+ | 19.60 | 8.15 | 5.68 | 79.14 |
13 | Male | 17.35 | 6.06 | 7.04 | 93.01 |
N . | Gender . | Lymphocyte T . | % . | Fas % . | FasL % . | Bcl-2 % . |
---|---|---|---|---|---|---|
15 | Female | CD4+ | 56.10 | 12.80 | 6.92 | 96.90 |
13 | Male | 38.15 | 9.89 | 8.94 | 97.40 | |
15 | Female | CD8+ | 19.60 | 8.15 | 5.68 | 79.14 |
13 | Male | 17.35 | 6.06 | 7.04 | 93.01 |
No relevant conflicts of interest to declare.
Author notes
Asterisk with author names denotes non-ASH members.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal